Agios Pharmaceuticals, Inc.
AGIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001439222
In the last 90 days, Agios Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 1 sale; 238 institutions reported holding it in 13F filings for Q2 2026, worth $2.45B in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding Agios Pharmaceuticals, Inc. changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Of which not filed for Q3 2023 | Q3 2023 | Change |
|---|---|---|---|---|
| Holders | 153 | 1 | 146 | −6 |
| Shares | 59.4M | 882.4K | 59.0M | +484.5K (+0.8%) |
| Value | $1.68B | $25.0M | $1.46B | −$191.4M (−11.6%) |
1 institution that held it in Q2 2023 haven't filed for Q3 2023 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Agios Pharmaceuticals, Inc. at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Pictet Asset Management Holding SA | 890,684 | $22.0M | 0.03% |
| Deep Track Capital, LP | 422,247 | $10.5M | 0.41% |
| Frazier Life Sciences Management, L.P. | 292,002 | $7.23M | 0.48% |
| Marshall Wace, LLP | 58,040 | $1.44M | 0.00% |
| SG Americas Securities, LLC | 24,531 | $607.0K | 0.01% |
| Squarepoint Ops LLC | 17,107 | $423.4K | 0.00% |
| Henshaw Capital LLC | 13,882 | $343.6K | 0.02% |
| Comerica Bank | 115 | $2.85K | 0.00% |
| Bell Investment Advisors, Inc | 31 | $768 | 0.00% |
| Steward Financial Group LLC | 9 | $0 | 0.00% |
Sold out (16)
Institutions that held Agios Pharmaceuticals, Inc. at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Jacobs Levy Equity Management, Inc | 144,611 | $4.10M |
| ExodusPoint Capital Management, LP | 120,363 | $3.41M |
| Connor, Clark & Lunn Investment Management Ltd. | 80,083 | $2.27M |
| Ergoteles LLC | 53,129 | $1.50M |
| Capital Fund Management S.A. | 41,455 | $1.17M |
| Public Employees Retirement System of Ohio | 27,010 | $765.0K |
| Capula Management Ltd | 24,380 | $690.4K |
| Graham Capital Management, L.P. | 16,958 | $480.3K |
| Franklin Resources Inc | 10,021 | $283.8K |
| E Fund Management Co., Ltd. | 8,793 | $249.0K |
| AQR Capital Management LLC | 7,717 | $217.3K |
| Parallax Volatility Advisers, L.P. | 2,102 | $59.5K |
| Harbor Investment Advisory, LLC | 1,375 | $38.9K |
| Versant Capital Management, Inc | 64 | $1.81K |
| Tilia Fiduciary Partners, Inc. | 38 | $1.08K |
| Disciplined Investments, LLC | 2 | $57 |
Not filed for Q3 2023 yet (1)
Institutions that held Agios Pharmaceuticals, Inc. at the end of Q2 2023 and haven't filed a 13F for Q3 2023. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| Pictet Asset Management SA | 882,402 | $25.0M |